
The global API Process Development and Manufacturing market is projected to reach US$ 8474.3 million in 2029, increasing from US$ 5864 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole API Process Development and Manufacturing 91ÖÆÆ¬³§.
Key companies engaged in the API Process Development and Manufacturing industry include NUVISAN, Cedarburg Pharmaceuticals, WuXi STA, Dalton Pharma Services, SPERA PHARMA, Esco Aster, API Pharma Tech, Novasep and Almac, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of API Process Development and Manufacturing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole API Process Development and Manufacturing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global API Process Development and Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
NUVISAN
Cedarburg Pharmaceuticals
WuXi STA
Dalton Pharma Services
SPERA PHARMA
Esco Aster
API Pharma Tech
Novasep
Almac
Lonza
Sambi Pharma
CordenPharma
Carbogen Amcis
Azis Labs
Biocon
Segment by Type
Small Molecule API Process Development and Manufacturing
Large Molecule API Process Development and Manufacturing
Segment by Application
Pharmaceutical
Clinical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The API Process Development and Manufacturing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global API Process Development and Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Small Molecule API Process Development and Manufacturing
1.2.3 Large Molecule API Process Development and Manufacturing
1.3 Market by Application
1.3.1 Global API Process Development and Manufacturing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Clinical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global API Process Development and Manufacturing Market Perspective (2018-2029)
2.2 API Process Development and Manufacturing Growth Trends by Region
2.2.1 Global API Process Development and Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 API Process Development and Manufacturing Historic Market Size by Region (2018-2023)
2.2.3 API Process Development and Manufacturing Forecasted Market Size by Region (2024-2029)
2.3 API Process Development and Manufacturing Market Dynamics
2.3.1 API Process Development and Manufacturing Industry Trends
2.3.2 API Process Development and Manufacturing Market Drivers
2.3.3 API Process Development and Manufacturing Market Challenges
2.3.4 API Process Development and Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top API Process Development and Manufacturing Players by Revenue
3.1.1 Global Top API Process Development and Manufacturing Players by Revenue (2018-2023)
3.1.2 Global API Process Development and Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global API Process Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by API Process Development and Manufacturing Revenue
3.4 Global API Process Development and Manufacturing Market Concentration Ratio
3.4.1 Global API Process Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by API Process Development and Manufacturing Revenue in 2022
3.5 API Process Development and Manufacturing Key Players Head office and Area Served
3.6 Key Players API Process Development and Manufacturing Product Solution and Service
3.7 Date of Enter into API Process Development and Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 API Process Development and Manufacturing Breakdown Data by Type
4.1 Global API Process Development and Manufacturing Historic Market Size by Type (2018-2023)
4.2 Global API Process Development and Manufacturing Forecasted Market Size by Type (2024-2029)
5 API Process Development and Manufacturing Breakdown Data by Application
5.1 Global API Process Development and Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global API Process Development and Manufacturing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America API Process Development and Manufacturing Market Size (2018-2029)
6.2 North America API Process Development and Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America API Process Development and Manufacturing Market Size by Country (2018-2023)
6.4 North America API Process Development and Manufacturing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe API Process Development and Manufacturing Market Size (2018-2029)
7.2 Europe API Process Development and Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe API Process Development and Manufacturing Market Size by Country (2018-2023)
7.4 Europe API Process Development and Manufacturing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific API Process Development and Manufacturing Market Size (2018-2029)
8.2 Asia-Pacific API Process Development and Manufacturing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific API Process Development and Manufacturing Market Size by Region (2018-2023)
8.4 Asia-Pacific API Process Development and Manufacturing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America API Process Development and Manufacturing Market Size (2018-2029)
9.2 Latin America API Process Development and Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America API Process Development and Manufacturing Market Size by Country (2018-2023)
9.4 Latin America API Process Development and Manufacturing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa API Process Development and Manufacturing Market Size (2018-2029)
10.2 Middle East & Africa API Process Development and Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa API Process Development and Manufacturing Market Size by Country (2018-2023)
10.4 Middle East & Africa API Process Development and Manufacturing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NUVISAN
11.1.1 NUVISAN Company Detail
11.1.2 NUVISAN Business Overview
11.1.3 NUVISAN API Process Development and Manufacturing Introduction
11.1.4 NUVISAN Revenue in API Process Development and Manufacturing Business (2018-2023)
11.1.5 NUVISAN Recent Development
11.2 Cedarburg Pharmaceuticals
11.2.1 Cedarburg Pharmaceuticals Company Detail
11.2.2 Cedarburg Pharmaceuticals Business Overview
11.2.3 Cedarburg Pharmaceuticals API Process Development and Manufacturing Introduction
11.2.4 Cedarburg Pharmaceuticals Revenue in API Process Development and Manufacturing Business (2018-2023)
11.2.5 Cedarburg Pharmaceuticals Recent Development
11.3 WuXi STA
11.3.1 WuXi STA Company Detail
11.3.2 WuXi STA Business Overview
11.3.3 WuXi STA API Process Development and Manufacturing Introduction
11.3.4 WuXi STA Revenue in API Process Development and Manufacturing Business (2018-2023)
11.3.5 WuXi STA Recent Development
11.4 Dalton Pharma Services
11.4.1 Dalton Pharma Services Company Detail
11.4.2 Dalton Pharma Services Business Overview
11.4.3 Dalton Pharma Services API Process Development and Manufacturing Introduction
11.4.4 Dalton Pharma Services Revenue in API Process Development and Manufacturing Business (2018-2023)
11.4.5 Dalton Pharma Services Recent Development
11.5 SPERA PHARMA
11.5.1 SPERA PHARMA Company Detail
11.5.2 SPERA PHARMA Business Overview
11.5.3 SPERA PHARMA API Process Development and Manufacturing Introduction
11.5.4 SPERA PHARMA Revenue in API Process Development and Manufacturing Business (2018-2023)
11.5.5 SPERA PHARMA Recent Development
11.6 Esco Aster
11.6.1 Esco Aster Company Detail
11.6.2 Esco Aster Business Overview
11.6.3 Esco Aster API Process Development and Manufacturing Introduction
11.6.4 Esco Aster Revenue in API Process Development and Manufacturing Business (2018-2023)
11.6.5 Esco Aster Recent Development
11.7 API Pharma Tech
11.7.1 API Pharma Tech Company Detail
11.7.2 API Pharma Tech Business Overview
11.7.3 API Pharma Tech API Process Development and Manufacturing Introduction
11.7.4 API Pharma Tech Revenue in API Process Development and Manufacturing Business (2018-2023)
11.7.5 API Pharma Tech Recent Development
11.8 Novasep
11.8.1 Novasep Company Detail
11.8.2 Novasep Business Overview
11.8.3 Novasep API Process Development and Manufacturing Introduction
11.8.4 Novasep Revenue in API Process Development and Manufacturing Business (2018-2023)
11.8.5 Novasep Recent Development
11.9 Almac
11.9.1 Almac Company Detail
11.9.2 Almac Business Overview
11.9.3 Almac API Process Development and Manufacturing Introduction
11.9.4 Almac Revenue in API Process Development and Manufacturing Business (2018-2023)
11.9.5 Almac Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza API Process Development and Manufacturing Introduction
11.10.4 Lonza Revenue in API Process Development and Manufacturing Business (2018-2023)
11.10.5 Lonza Recent Development
11.11 Sambi Pharma
11.11.1 Sambi Pharma Company Detail
11.11.2 Sambi Pharma Business Overview
11.11.3 Sambi Pharma API Process Development and Manufacturing Introduction
11.11.4 Sambi Pharma Revenue in API Process Development and Manufacturing Business (2018-2023)
11.11.5 Sambi Pharma Recent Development
11.12 CordenPharma
11.12.1 CordenPharma Company Detail
11.12.2 CordenPharma Business Overview
11.12.3 CordenPharma API Process Development and Manufacturing Introduction
11.12.4 CordenPharma Revenue in API Process Development and Manufacturing Business (2018-2023)
11.12.5 CordenPharma Recent Development
11.13 Carbogen Amcis
11.13.1 Carbogen Amcis Company Detail
11.13.2 Carbogen Amcis Business Overview
11.13.3 Carbogen Amcis API Process Development and Manufacturing Introduction
11.13.4 Carbogen Amcis Revenue in API Process Development and Manufacturing Business (2018-2023)
11.13.5 Carbogen Amcis Recent Development
11.14 Azis Labs
11.14.1 Azis Labs Company Detail
11.14.2 Azis Labs Business Overview
11.14.3 Azis Labs API Process Development and Manufacturing Introduction
11.14.4 Azis Labs Revenue in API Process Development and Manufacturing Business (2018-2023)
11.14.5 Azis Labs Recent Development
11.15 Biocon
11.15.1 Biocon Company Detail
11.15.2 Biocon Business Overview
11.15.3 Biocon API Process Development and Manufacturing Introduction
11.15.4 Biocon Revenue in API Process Development and Manufacturing Business (2018-2023)
11.15.5 Biocon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
NUVISAN
Cedarburg Pharmaceuticals
WuXi STA
Dalton Pharma Services
SPERA PHARMA
Esco Aster
API Pharma Tech
Novasep
Almac
Lonza
Sambi Pharma
CordenPharma
Carbogen Amcis
Azis Labs
Biocon
Ìý
Ìý
*If Applicable.
